Home
About Us
- Our Team
Projects
Training for FGS Recognition
BRIGHT Academy
News
Contact Us

Select Page

Project Partner

Search

Latest Posts

Newsletter: February 2026
NEWSLETTER: May 2025 Status for the Alpha trial
NEWSLETTER November 2024
FGSNoMore Podcast On Spotify
FGSNoMore Podcast Series with Kabelo Khetsi 1

FGS feed from PubMed

"We don't know schistosomiasis can affect the female reproductive system and increase the risk of HIV": A mixed-methods analysis reveals gaps in risk factor determinants and health consequences of female genital schistosomiasis in Southern Chad
Molecular, parasitological and clinical diagnosis of female genital schistosomiasis: A diagnostic yield and comparative accuracy study using latent class analysis
Development of a multiplex quantitative real-time PCR (qPCR) assay for simultaneous detection of Schistosoma haematobium and high-risk human papillomaviruses
Unexpected uterine microhabitat of Schistosoma infection: a migrant case of female genital schistosomiasis in Europe
Prevalence and associated risk factors of self-reported symptoms suggestive of female genital schistosomiasis (FGS) among women in KwaZulu-Natal, South Africa

About DUALSAVE-FGS

DUALSAVE-FGS is a partnership of nine African and European institutions developing a cost-effective joint screening method for Female Genital Schistosomiasis and cervical cancer.

DUALSAVE-FGS is proud to provide free virtual training on FGS diagnosis and management for gynaecologists, doctors and frontline primary healthcare nurses.

We are currently clinically testing the Spectral Artificial Vision (SAVE) colposcope, invented and developed by our partner QCELL, a biophotonics imaging company based in Greece.

SAVE is a low-cost, hand-held digital colposcope, integrating the most advanced spectral imaging and machine learning technologies with the possibility for large-scale implementation.

SAVE is capable of safely identifying cervical (pre-)cancer and hopefully FGS, instantly, and without being in contact with the patient.

Alongside the study, we will be collecting patients’ and health professionals’ opinions on this new and innovative diagnostic method.



Site

Browse a page

Home

About Us

Project Summary

BRIGHT Academy

News

Contact Us

Privacy Policy

Contact

Get In Touch

brightresearch.cbthr@gmail.com

M-F: 8am-5pm

download

Translate »